Vineet Kalathur Raghu, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Computer Graphics | 2 | 2021 | 360 | 0.710 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2017 | 731 | 0.510 |
Why?
|
Early Detection of Cancer | 5 | 2022 | 3086 | 0.500 |
Why?
|
Lung Neoplasms | 5 | 2022 | 13096 | 0.490 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1623 | 0.380 |
Why?
|
Drug Discovery | 1 | 2017 | 1058 | 0.350 |
Why?
|
Computational Biology | 1 | 2021 | 3523 | 0.330 |
Why?
|
Critical Illness | 1 | 2021 | 2670 | 0.330 |
Why?
|
Databases, Factual | 2 | 2021 | 7730 | 0.280 |
Why?
|
Smoking | 2 | 2020 | 8986 | 0.260 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9438 | 0.250 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2020 | 3256 | 0.230 |
Why?
|
Vascular Diseases | 2 | 2022 | 1161 | 0.220 |
Why?
|
X-Rays | 1 | 2021 | 301 | 0.190 |
Why?
|
Urinary Sphincter, Artificial | 1 | 2020 | 24 | 0.190 |
Why?
|
Penile Prosthesis | 1 | 2020 | 38 | 0.190 |
Why?
|
Urethral Diseases | 1 | 2020 | 53 | 0.180 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2021 | 528 | 0.180 |
Why?
|
Pericardial Effusion | 1 | 2021 | 247 | 0.170 |
Why?
|
Meningocele | 1 | 2019 | 45 | 0.170 |
Why?
|
Stroke | 1 | 2021 | 9981 | 0.160 |
Why?
|
Hemangioblastoma | 1 | 2019 | 70 | 0.160 |
Why?
|
Cranial Fossa, Posterior | 1 | 2019 | 139 | 0.160 |
Why?
|
Infratentorial Neoplasms | 1 | 2019 | 94 | 0.160 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2022 | 501 | 0.150 |
Why?
|
Pregnancy, Ectopic | 1 | 2018 | 141 | 0.150 |
Why?
|
Microvessels | 1 | 2021 | 544 | 0.150 |
Why?
|
Microcirculation | 1 | 2022 | 1286 | 0.150 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2019 | 153 | 0.140 |
Why?
|
Mendelian Randomization Analysis | 1 | 2021 | 967 | 0.140 |
Why?
|
Databases, Protein | 1 | 2017 | 383 | 0.130 |
Why?
|
Software | 2 | 2020 | 4442 | 0.130 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 13668 | 0.120 |
Why?
|
Macular Degeneration | 1 | 2022 | 981 | 0.120 |
Why?
|
Retina | 2 | 2024 | 2616 | 0.120 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15070 | 0.120 |
Why?
|
Radiography | 2 | 2023 | 7022 | 0.120 |
Why?
|
Genome-Wide Association Study | 2 | 2024 | 12264 | 0.120 |
Why?
|
Tomography, Optical Coherence | 2 | 2024 | 2657 | 0.110 |
Why?
|
Lung Diseases | 1 | 2023 | 1885 | 0.110 |
Why?
|
Neoplasms | 2 | 2020 | 21672 | 0.110 |
Why?
|
Humans | 24 | 2024 | 744220 | 0.100 |
Why?
|
Radiation Dosage | 1 | 2019 | 1928 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 4 | 2022 | 20123 | 0.090 |
Why?
|
Acute Coronary Syndrome | 1 | 2023 | 2337 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2019 | 5076 | 0.080 |
Why?
|
Plaque, Atherosclerotic | 1 | 2020 | 1519 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2020 | 3047 | 0.080 |
Why?
|
Mass Screening | 2 | 2022 | 5252 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12961 | 0.070 |
Why?
|
Male | 12 | 2023 | 350027 | 0.070 |
Why?
|
Smoking Cessation | 1 | 2019 | 2071 | 0.070 |
Why?
|
Female | 12 | 2023 | 380197 | 0.070 |
Why?
|
Middle Aged | 9 | 2023 | 213367 | 0.070 |
Why?
|
Electronic Health Records | 1 | 2022 | 4463 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2021 | 4252 | 0.070 |
Why?
|
Genomics | 1 | 2021 | 5722 | 0.070 |
Why?
|
Lung | 2 | 2023 | 9852 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10949 | 0.060 |
Why?
|
Medicare | 1 | 2022 | 6566 | 0.060 |
Why?
|
Atherosclerosis | 1 | 2020 | 3444 | 0.060 |
Why?
|
Models, Statistical | 1 | 2019 | 5102 | 0.060 |
Why?
|
Phenotype | 1 | 2021 | 16365 | 0.060 |
Why?
|
Algorithms | 2 | 2021 | 13885 | 0.060 |
Why?
|
Aged | 5 | 2022 | 163253 | 0.060 |
Why?
|
Models, Biological | 1 | 2019 | 9582 | 0.050 |
Why?
|
Risk Assessment | 2 | 2020 | 23337 | 0.050 |
Why?
|
Aging | 1 | 2021 | 8661 | 0.050 |
Why?
|
Hypertension | 1 | 2022 | 8480 | 0.050 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 16687 | 0.050 |
Why?
|
Thorax | 1 | 2023 | 547 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2020 | 11728 | 0.040 |
Why?
|
Retinal Pigment Epithelium | 1 | 2022 | 302 | 0.040 |
Why?
|
Adult | 6 | 2024 | 214035 | 0.040 |
Why?
|
Child, Preschool | 1 | 2021 | 40992 | 0.040 |
Why?
|
Risk Factors | 3 | 2020 | 72280 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 3 | 2021 | 35423 | 0.040 |
Why?
|
Urethra | 1 | 2020 | 408 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2024 | 15161 | 0.040 |
Why?
|
Face | 1 | 2024 | 994 | 0.040 |
Why?
|
Young Adult | 2 | 2021 | 56436 | 0.040 |
Why?
|
Prospective Studies | 1 | 2021 | 53280 | 0.040 |
Why?
|
Biological Specimen Banks | 1 | 2022 | 712 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2019 | 15294 | 0.040 |
Why?
|
Radiography, Thoracic | 1 | 2023 | 1265 | 0.040 |
Why?
|
Myocardial Revascularization | 1 | 2020 | 841 | 0.030 |
Why?
|
Triage | 1 | 2023 | 976 | 0.030 |
Why?
|
Prognosis | 3 | 2022 | 29050 | 0.030 |
Why?
|
Chest Pain | 1 | 2023 | 1114 | 0.030 |
Why?
|
Systems Biology | 1 | 2019 | 469 | 0.030 |
Why?
|
Sample Size | 1 | 2018 | 846 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2022 | 1782 | 0.030 |
Why?
|
United States | 1 | 2022 | 69867 | 0.030 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2020 | 451 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2021 | 20817 | 0.030 |
Why?
|
Child | 1 | 2021 | 77679 | 0.030 |
Why?
|
Adolescent | 1 | 2021 | 85759 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2020 | 2715 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2023 | 77426 | 0.030 |
Why?
|
Disease | 1 | 2018 | 681 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1854 | 0.020 |
Why?
|
Disease Management | 1 | 2022 | 2458 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2017 | 63119 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2020 | 1955 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2759 | 0.020 |
Why?
|
Pregnancy | 2 | 2022 | 29142 | 0.020 |
Why?
|
Internet | 1 | 2020 | 3063 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9311 | 0.020 |
Why?
|
Liver | 1 | 2021 | 7472 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14726 | 0.020 |
Why?
|
Disease Progression | 1 | 2020 | 13280 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 19907 | 0.010 |
Why?
|
Cohort Studies | 1 | 2022 | 40559 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40063 | 0.010 |
Why?
|